By inhibiting NNMT, 5-Amino-1MQ essentially allows the body's natural metabolic machinery to operate more efficiently, potentially leading to enhanced fat metabolism and improved energy expenditure
Likewise, little is known about how these drugs affect body dissatisfaction, another common feature among people living with obesity and binge eating disorder
So I think seeing the progression of that and looking at outcome studies will be key before we make a decision of whether or not we want to include that in our care. Road to Reimbursement Because GLP-1s are a new drug within health care in general and there are not yet any clinical standards for its use across substance use disorder care, serious mental illnesses or eating disorders, the road to eventual reimbursement for including it in care is one all practitioners told BHB they will be closely monitoring
This typically includes regular assessment of vital signs (heart rate, blood pressure), weight and body composition, laboratory parameters (electrolytes, kidney function, lipid panel, hemoglobin A1c if diabetic), mental health status, and gastrointestinal symptoms
In conditions like Long COVID, researchers have identified widespread endothelial dysfunctiondamage to the inner lining of the blood vesselsand the presence of persistent micro-clots
Our goal is to get our patients to their goal weight, and while they are on their weight loss journey, we work diligently to equip you with healthy eating and exercise habits that allow for a positive lifestyle change in order to maintain the weight loss once the course of medication is complete